SAVAW Live signals | Maximize Profits with Getagraph.com

BUY 123720 min ago

@ $7.14

Issued: 12 Feb 2024 @ 09:30

Return: -99.58%

Previous signal: Feb 6 - 14:44

Previous signal: Sell

Return: -3.12 %

Live Chart Being Loaded With Signals

Commentary (2 May 2024 @ 16:00):

Stats
Today's Volume	2.51M
Average Volume	322 957
Market Cap	1.30M
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.00400 (15.38%)

Volume Correlation

Long: -0.04 (neutral)

Short: -0.88 (strong negative)

Signal:(45.286) Neutral

Cassava Sciences, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Cassava Sciences, Inc. Correlation - Currency/Commodity

0.21
( neutral )

0.50
( neutral )

0.00
( neutral )

-0.21
( neutral )

Financial Reports:

No articles found.

Cassava Sciences, Inc.

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company was incorporated in 1998 and is based in Austin, Texas.